Clinical Focus 
 Therapy Update

A GP guide to SGLT2 inhibitors in type 2 diabetes

The benefits and adverse effects of this new class of medications
Dr David Jesudason Dr Shilpanjali Jesudason
0
20 January 2020
Save
ClosePlease login

Diabetes affects approximately 1.2 million Australians, with type 2 diabetes accounting for up to 90% of cases.1-3

The risk of adverse kidney outcomes in patients with type 2 diabetes remains high.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .